State-of-the-art of irritable bowel syndrome and inflammatory bowel disease research in 2008

World Journal of Gastroenterology

Volumn 14, Issue 17, 2008, Pages 2625-2629

  McFarland, Lynne V ^a,b  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Inflammatory bowel disease; Irritable bowel syndrome

Indexed keywords

ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; CORTICOSTEROID; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; MESALAZINE; OCTREOTIDE; PROBIOTIC AGENT; SEROTONIN 4 ANTAGONIST; SEROTONIN AGONIST; SPASMOLYTIC AGENT; STEROID; TEGASEROD; TUMOR NECROSIS FACTOR ANTIBODY;

CLINICAL PROTOCOL; CLINICAL TRIAL; COLON RESECTION; CROHN DISEASE; DEMYELINATING DISEASE; DIAGNOSTIC PROCEDURE; DIARRHEA; DIET THERAPY; DRUG EFFICACY; DRUG MECHANISM; EDITORIAL; ENTERITIS; HEALTH CARE COST; HEALTH CARE SYSTEM; HERBAL MEDICINE; HUMAN; HYPNOSIS; INCIDENCE; INFECTION; IRRITABLE COLON; LYMPHOMA; MEDICAL CARE; MEDICAL RESEARCH; NONHUMAN; PATHOGENESIS; REMISSION; RISK FACTOR; TUBERCULOSIS; ULCERATIVE COLITIS; UNITED KINGDOM; UNITED STATES; CHRONIC DISEASE; COST OF ILLNESS; GASTROENTEROLOGY; TREATMENT OUTCOME;

BIOMEDICAL RESEARCH; CHRONIC DISEASE; COST OF ILLNESS; GASTROENTEROLOGY; HEALTH CARE COSTS; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; IRRITABLE BOWEL SYNDROME; RISK FACTORS; TREATMENT OUTCOME;

EID: 49649122318     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.2625     Document Type: Editorial

References (38)

1. Lee SY, Kim JH, Sung IK, Park HS, Jin CJ, Choe WH, Kwon SY, Lee CH, Choi KW. Irritable bowel syndrome is more common in women regardless of the menstrual phase: a Rome II-based survey. J Korean Med Sci 2007; 22: 851-854
2. Roberts SE, Williams JG, Yeates D, Goldacre MJ. Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn's disease: record linkage studies. BMJ 2007; 335: 1033
3. Cohen RD, Thomas T. Economics of the use of biologics in the treatment of inflammatory bowel disease. Gastroenterol Clin North Am 2006; 35: 867-882
4. Cremonini F, Talley NJ. Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors. Gastroenterol Clin North Am 2005; 34: 189-204
5. Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, Gemmen E, Shah S, Avdic A, Rubin R. The burden of selected digestive diseases in the United States. Gastroenterology 2002; 122: 1500-1511
6. Agrawal A, Whorwell PJ. Irritable bowel syndrome: diagnosis and management. BMJ 2006; 332: 280-283
7. Foxx-Orenstein A. IBS-review and what's new. MedGenMed 2006; 8: 20
8. McCrea GL, Miaskowski C, Stotts NA, Macera L, Varma MG. Pathophysiology of constipation in the older adult. World J Gastroenterol 2008; 14: 2631-2638
9. Choung RS, Locke GR 3rd, SchlecR CD, Zinsmeister AR, Talley NJ. Cumulative incidence of chronic constipation: a population-based study 1988-2003. Aliment Pharmacol Ther 2007; 26: 1521-1528
10. Ladep NG, Okeke EN, Samaila AA, Agaba EI, Ugoya SO, Puepet FH, Malu AO. Irritable bowel syndrome among patients attending General Outpatients' clinics in Jos, Nigeria. Eur J Gastroenterol Hepatol 2007; 19: 795-799
11. Barbara G, De Giorgio I, Stanghellini V, Cremon C, Corinaldesi R. A role for inflammation in irritable bowel syndrome? Gut 2002; 51 Suppl 1: i41-i44
12. Hammerle CW, Surawicz CM. Updates on treatment of irritable bowel syndrome. World J Gastroenterol 2008; 14: 2639-2649
13. Barbara G, Stanghellini Y, Cremon C, De Giorgio R, Corinaldesi R. Almost all irritable bowel syndromes are post-infectious and respond to probiotics: controversial issues. Dig Dis 2007; 25: 245-248
14. McFarland LV. Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med Infect Dis 2007; 5: 97-105
15. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006; 101: 812-822
16. McFarland LV, Dublin S. Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol 2008; 14: 2650-2661
17. Economou M, Pappas G. New global map of Crohn's disease: Genetic, environmental, and socioeconomic correlations. Inflamm Bowel Dis 2007; 14: 709-720
18. Lok KH, Hung HG, Ng CH, Li KK, Li KF, Szeto ML. The epidemiology and clinical characteristics of Crohn's disease in the Hong Kong Chinese population: experiences from a regional hospital. Hong Kong Med J 2007; 13: 436-441
19. Economou M, Filis G, Tsianou Z, Alamanos J, Kogevinas A, Masalas K, Petrou A, Tsianos EV. Crohn's disease incidence evolution in North-western Greece is not associated with alteration of NOD2/CARD15 variants. World J Gastroenterol 2007; 13: 5116-5120
20. Wang Y, Ouyang Q. Ulcerative colitis in China: retrospective analysis of 3100 hospitalized patients. J Gastroenterol Hepatol 2007; 22: 1450-1455
21. Hutfless SM, Weng X, Liu L, Allison J, Herrinton LJ. Mortality bv medication use among patients with inflammatory bowel disease, 1996-2003. Gastroenterology 2007; 133: 1779-1786
22. Hoie O, Wolters FL, Riis L, Bernklev T, Aamodt G, Clofent J, Tsianos E, Beltrami M, Odes S, Munkholm P, Vatn M, Stockbrugger RW, Moum B. Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology 2007; 132: 507-515
23. Elmer GW, McFarland LV, McFarland M. Inflammatory bowel disease, irritable bowel syndrome and digestive problems, Chapter 6. In: The Power of Probiotics. New York: Haworth Press, 2007: 111-130
24. Zisman TL, Rubin DT. Colorectal. cancer and dysplasia in inflammatory bowel disease. World J Gastroenterol 2008; 14: 2662-2669
25. Kugathasan S, Nebel J, Skelton JA, Markowitz J, Keljo D, Rosh J, LeLeiko N, Mack D, Griffiths A, Bousvaros A, Evans J, Mezoff A, Moyer S, Oliva-Hemker M, Otley A, Pfefferkorn M, Crandall W, Wyllie R, Hyams J. Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts. J Pediatr 2007; 151: 523-527
26. Seksik P, Sokol H, Lepage P, Vasquez N, Manichanh C, Mangin I, Pochart P, Dore J, Marteau P. Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther 2006; 24 Suppl 3: 11-18
27. Koloski NA, Bret L, Radford-Smith G. Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature. World J Gastroenterol 2008; 14: 165-173
28. Feller M, Huwiler K, Stephan R, Altpeter E, Shang A, Furrer H, Pfyffer GE, Jemmi T, Baumgartner A, Egger M. Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Infect Dis 2007; 7: 607-613
29. Ruemmele FM, El Khoury MG, Talbotec C, Maurage C, Mougenot JF, Schmitz J, Goulet O. Characteristics of inflammatory bowel disease with onset during the first year of life. J Pediatr Gastroenterol Nutr 2006; 43: 603-609
30. Lewis CM, Whitwell SC, Forbes A, Sanderson J, Mathew CG, Marteau TM. Estimating risks of common complex diseases across genetic and environmental factors: the example of Crohn disease. J Med Genet 2007; 44: 689-694
31. Kugathasan S, Fiocchi C. Progress in basic inflammatory bowel disease research. Semin Pediatr Surg 2007; 16: 146-153
32. Shergill AK, Terdiman JP. Controversies in the treatment of Crohn's disease: The case for an accelerated step-up treatment approach. World J Gastroenterol 2008; 14: 2670-2677
33. Beckler DR, Elwasila S, Ghobrial G, Valentine JF, Naser SA. Correlation between rpoB gene mutation in Mycobacterium. avium subspecies paratuberculosis and clinical rifabutin and rifampicin resistance for treatment of Crohn's disease. World J Gastroenterol 2008; 14: 2723-2730
34. Yu ED, Shao Z, Shen B. Pouchitis. World J Gastroenterol 2007; 13: 5598-5604
35. Hwang JM, Varma MG. Surgery for inflammatory bowel disease. World J Gastroenterol 2008; 14: 2678-2690
36. Mallon P, McKay D, Kirk S, Gardiner K. Probiotics for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2007: CDO05573
37. Gerasimidis K, McGrogan P, Hassan K, Edwards CA. Dietary modifications, nutritional supplements and alternative medicine in paediatric patients with inflammatory bowel disease. Aliment Pharmacol Ther 2008; 27: 155-165
38. Ewaschuk JB, Dieleman LA. Probiotics and prebiotics in chronic inflammatory bowel diseases. World J Gastroenterol 2006; 12: 5941-5950